Sanofi India Board Approves 70th AGM, Rs. 48 Dividend and Independent Director

Sanofi India Limited has announced significant corporate developments following its Board of Directors meeting held on March 25, 2026. The pharmaceutical company disclosed multiple key decisions including the scheduling of its Annual General Meeting, dividend approval, and a new director appointment, all communicated in compliance with SEBI regulations.

Annual General Meeting and Dividend Details

The Board has approved the convening of the company's 70th Annual General Meeting with specific arrangements for shareholder participation:

Parameter: Details AGM Date: Wednesday, April 29, 2026 Time: 3:30 PM (IST) Mode: Video Conferencing/Audio-Visual Means Final Dividend: Rs. 48.00 per equity share Record Date: Wednesday, April 22, 2026 Book Closure: April 23-29, 2026 (both days inclusive)

The final dividend of Rs. 48.00 per equity share of Rs. 10.00 each for the Financial Year ended December 31, 2025, was previously recommended by the Board on February 25, 2026, and is now subject to member approval at the upcoming AGM.

New Independent Director Appointment

Based on the Nomination and Remuneration Committee's recommendation, the Board has approved the appointment of Mr. Siraj Azmat Chaudhry as Additional Director and Independent Director. The appointment details are structured as follows:

Appointment Details: Information Director Name: Mr. Siraj Azmat Chaudhry DIN: 00161853 Position: Additional Director & Independent Director Term Duration: 5 consecutive years Term Period: April 1, 2026 to March 31, 2031 Status: Subject to AGM approval

Director Profile and Experience

Mr. Siraj Azmat Chaudhry brings extensive experience to Sanofi India's Board, with over 35 years of professional experience including 20 years in leadership roles across agriculture and food sectors. He holds an MBA from the Indian Institute of Foreign Trade and B.Com (Hons) from Shri Ram College of Commerce, University of Delhi.

Notably, he served as Chairman of Cargill India from 2008-2018, where he led the expansion of Cargill's Food Business into a Rs. 5,000 crore entity. He currently serves as Independent Director on boards of Jubilant Ingrevia Ltd., Carrier Air Conditioning and Refrigeration India, Bikaji Foods International, and Triveni Engineering and Industries Ltd.

Regulatory Compliance and Meeting Schedule

The Board meeting commenced at 11:00 AM and concluded at 12:05 PM on March 25, 2026, conducted in full compliance with SEBI regulations. All disclosures have been made in accordance with Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Meeting Details: Information Meeting Duration: 11:00 AM to 12:05 PM Compliance Officer: Haresh Vala Regulatory Framework: SEBI Regulation 30 Document Status: Digitally signed

The announcement was signed by Haresh Vala, Company Secretary and Compliance Officer, ensuring continued stakeholder engagement and regulatory adherence.

Sanofi India Limited has issued a public notice regarding the mandatory transfer of equity shares to the Investor Education and Protection Fund (IEPF) Authority for shareholders who have not claimed their dividends for seven consecutive years or more.

Regulatory Compliance Notice

The company has published newspaper advertisements on March 14, 2026, in Business Standard (English) and Sakal (Marathi) newspapers, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This notice addresses shareholders whose shares are liable for transfer to the IEPF as per Section 124(6) of the Companies Act, 2013.

Transfer Requirements and Timeline

Under the Companies Act, 2013 and the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016, companies must transfer all shares to the IEPF demat account where dividends have remained unclaimed for seven consecutive years or more.

Key Details: Information Notice Date: March 13, 2026 Publication Date: March 14, 2026 Deadline for Claims: June 13, 2026 Starting Period: Final dividend for FY 2018 Affected Dividends: All subsequent declared dividends

Sanofi India has sent separate communications dated March 13, 2026, to all affected shareholders who have not encashed their final dividend for financial year 2018 and subsequent dividends declared by the company.

Shareholder Action Required

Shareholders are requested to forward requisite documents to either the company or its Registrar and Transfer Agent, MUGF Intime India Private Limited (formerly Link Intime India Private Limited), to claim unclaimed dividend amounts and shares. A comprehensive list of shareholders who have not encashed dividends for seven consecutive years is available on the company's website.

Recovery Process for Transferred Shares

Once shares are transferred to IEPF, all future benefits will be issued in favor of the IEPF Authority. However, shareholders can reclaim both unclaimed dividends and transferred shares by:

Making an online application in prescribed e-form IEPF-5

Obtaining an entitlement letter from the company

Submitting required documents as enumerated in the e-form

Following the procedure outlined on the IEPF website at www.iepf.gov.in

Contact Information

For queries related to this matter, shareholders can contact:

Contact Details: Information Registrar: MUGF Intime India Private Limited Address: C-101, Embassy 247, L.B.S Marg, Vikhroli (West), Mumbai - 400 083 Phone: +91 81081 16767 Email: investor.helpdesk@in.mpms.mugf.com

The notice emphasizes that no claims will be entertained against the company once shares are transferred to IEPF, making it crucial for eligible shareholders to act before the June 13, 2026 deadline.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.